Cipla narrows loss in Jan-March, misses forecasts | Reuters

MUMBAI Cipla Ltd, India's fifth-largest drugmaker by sales, reported a smaller quarterly loss for January-March, but missed expectations of a profit for the period.Net loss for the firm's fourth quarter narrowed to 617.9 million rupees ($9.56 million) from a loss of 928.3 million rupees a year earlier. Analysts on average had expected the firm would report a profit of 3.45 billion rupees. The quarter includes a one-off non-cash impairment charge of 21.42 billion rupees related to litigation expenses, and the company also took a provision of 560 million rupees related to its unit Cipla Biotech in the quarter, it said in a statement

Reuters May 25, 2017 16:44:51 IST
Cipla narrows loss in Jan-March, misses forecasts
| Reuters

Cipla narrows loss in JanMarch misses forecasts
 Reuters

MUMBAI Cipla Ltd, India's fifth-largest drugmaker by sales, reported a smaller quarterly loss for January-March, but missed expectations of a profit for the period.Net loss for the firm's fourth quarter narrowed to 617.9 million rupees ($9.56 million) from a loss of 928.3 million rupees a year earlier.

Analysts on average had expected the firm would report a profit of 3.45 billion rupees.

The quarter includes a one-off non-cash impairment charge of 21.42 billion rupees related to litigation expenses, and the company also took a provision of 560 million rupees related to its unit Cipla Biotech in the quarter, it said in a statement.

($1 = 64.6125 Indian rupees) (Reporting by Zeba Siddiqui in Mumbai; Editing by Edmund Blair)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. data suggest economic recovery may be weakening
Business

U.S. data suggest economic recovery may be weakening

By Howard Schneider WASHINGTON (Reuters) - The explosive surge in U.S. coronavirus cases this fall has left a question hanging: When will the economy take its own turn for the worse

Fed, ECB heads give COVID-19 vaccine cautious welcome
Business

Fed, ECB heads give COVID-19 vaccine cautious welcome

FRANKFURT/WASHINGTON (Reuters) - The heads of the Federal Reserve and the European Central Bank welcomed the encouraging results in trials of a vaccine candidate for the novel coronavirus but stressed that the economic outlook will remain uncertain. Fed chair Jay Powell and ECB President Christine Lagarde said the economy was still in for a tough time even if the development of a potential vaccine by U.S. drugmaker Pfizer and German partner BioNTech SE was reason for some optimism further ahead

India's October fuel demand marks first year-on-year gain in 8 months
Business

India's October fuel demand marks first year-on-year gain in 8 months

By Sumita Layek (Reuters) - India's fuel consumption in October registered its first year-on-year increase since February, as slowing coronavirus cases and increased mobility accelerated an economic recovery, data showed on Thursday.